Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Sumner

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
European Journal of Clinical Pharmacology|January 1, 1987
Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonismK Whyte, C R Jones, C A Howie, et al.
Food and Cosmetics Toxicology|August 1, 1980
The percutaneous absorption of lead-203 in humans from cosmetic preparations containing lead acetate, as assessed by whole-body counting and other techniquesM R Moore, P A Meredith, W S Watson, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Verapamil pharmacokinetics and apparent hepatic and renal blood flowP A Meredith, H L Elliott, F Pasanisi, et al.
Clinical Pharmacology and Therapeutics|July 1, 1977
Digoxin kinetics in patients with thyroid dysfunctionJ R Lawrence, D J Sumner, W J Kalk, et al.
European Journal of Clinical Pharmacology|January 1, 1982
The influence of protein binding on disopyramide clearanceS M Bryson, J R Lawrence, W H Steele, et al.
Pharmatherapeutica|January 1, 1980
A pharmacokinetic and clinical evaluation of iron poly (sorbitol-gluconic acid) complexB C Campbell, J R Lawrence, D J Sumner, et al.
Clinical Pharmacology and Therapeutics|May 1, 1978
Kinetic and dynamic comparison of piretanide and furosemideJ R Lawrence, A F Ansari, H L Elliott, et al.
Lancet (London, England)|February 26, 1983
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertensionP C Rubin, L Butters, D M Clark, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
European Journal of Clinical Pharmacology|January 1, 1987
Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonismK Whyte, C R Jones, C A Howie, et al.
Food and Cosmetics Toxicology|August 1, 1980
The percutaneous absorption of lead-203 in humans from cosmetic preparations containing lead acetate, as assessed by whole-body counting and other techniquesM R Moore, P A Meredith, W S Watson, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Verapamil pharmacokinetics and apparent hepatic and renal blood flowP A Meredith, H L Elliott, F Pasanisi, et al.
Clinical Pharmacology and Therapeutics|July 1, 1977
Digoxin kinetics in patients with thyroid dysfunctionJ R Lawrence, D J Sumner, W J Kalk, et al.
European Journal of Clinical Pharmacology|January 1, 1982
The influence of protein binding on disopyramide clearanceS M Bryson, J R Lawrence, W H Steele, et al.
Pharmatherapeutica|January 1, 1980
A pharmacokinetic and clinical evaluation of iron poly (sorbitol-gluconic acid) complexB C Campbell, J R Lawrence, D J Sumner, et al.
Clinical Pharmacology and Therapeutics|May 1, 1978
Kinetic and dynamic comparison of piretanide and furosemideJ R Lawrence, A F Ansari, H L Elliott, et al.
Lancet (London, England)|February 26, 1983
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertensionP C Rubin, L Butters, D M Clark, et al.
Pageof 6